Literature DB >> 5113467

Concurrence of hypernephroma and hypercalcemia.

M M Warren, D C Utz, P P Kelalis.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5113467      PMCID: PMC1397571          DOI: 10.1097/00000658-197111000-00019

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  6 in total

1.  PARATHYROID HORMONE-LIKE ACTIVITY IN A RENAL CARCINOMA PRODUCING HYPERCALCEMIA.

Authors:  B LYTTON; B ROSOF; J S EVANS
Journal:  J Urol       Date:  1965-02       Impact factor: 7.450

2.  Hypercalcemia in malignant disease without evidence of bone destruction.

Authors:  A GELLHORN; C H PLIMPTON
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

3.  Reversible hepatic dysfunction associated with hypernephroma.

Authors:  D C Utz; M M Warren; J A Gregg; J Ludwig; P P Kelalis
Journal:  Mayo Clin Proc       Date:  1970-03       Impact factor: 7.616

4.  The changing concept of hypernephroma.

Authors:  M M Warren; P P Kelalis; D C Utz
Journal:  J Urol       Date:  1970-09       Impact factor: 7.450

5.  Parathyroid hormone-secreting renal carcinoma associated with hypercalcemia and metabolic alkalosis.

Authors:  A S O'Grady; L J Morse; J B Lee
Journal:  Ann Intern Med       Date:  1965-11       Impact factor: 25.391

6.  Hypercalcaemia associated with adenocarcinoma of kidney without demonstrable bone lesions.

Authors:  W H Thomson; A B Karat
Journal:  Br Med J       Date:  1966-09-24
  6 in total
  5 in total

Review 1.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

2.  Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.

Authors:  Ganesh S Palapattu; Blaine Kristo; Jacob Rajfer
Journal:  Rev Urol       Date:  2002

3.  The differentiation of primary hyperparathyroidism from the hypercalcemia of malignancy.

Authors:  N B Ackerman; N Winer
Journal:  Ann Surg       Date:  1975-02       Impact factor: 12.969

Review 4.  Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature.

Authors:  Halit Karaca; Ayhan Lale; Mustafa Dikilitas; Metin Ozkan; Ozlem Er
Journal:  Med Oncol       Date:  2009-10-15       Impact factor: 3.064

5.  Asymptomatic kidney tumors incidentally diagnosed in two patients.

Authors:  A Witeska; A Borówka
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.